8-K: Kingsway Financial Reports Mixed Q1 2024 Results Amidst Economic Headwinds

Kingsway Financial Services Inc. reported a slight revenue decrease and a net loss for the first quarter of 2024, impacted by macroeconomic trends and higher claims expenses.

Summary

• Kingsway Financial Services Inc. announced its financial results for the three months ended March 31, 2024.
• Consolidated revenue saw a minor decrease of 0.9%, falling to $26.2 million from $26.4 million in the same period last year.
• The company experienced a net loss of $2.3 million, a significant shift from the net income of $27.9 million in the prior year, which included a $31.6 million non-recurring gain from debt extinguishment.
• Adjusted consolidated EBITDA was $2.1 million, down from $2.4 million year-over-year.
• The company's extended warranty business generated $16.7 million in revenue, consistent with the prior year, but saw a decrease in adjusted EBITDA due to higher claims expenses.
• KSX revenue decreased by 2.5% to $9.5 million, with adjusted EBITDA also declining due to softness in the nurse staffing business.
• The twelve-month run-rate adjusted EBITDA for operating companies is estimated to be between $16 million and $17 million.
• Kingsway repurchased 8,000 shares of its common stock at a cost of $0.1 million through May 8, 2024.
• The company's net debt stood at $34.9 million as of March 31, 2024, slightly down from $35.3 million at the end of 2023.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the reported net loss and decreased EBITDA, although there are some positive aspects such as expense management and future acquisition plans. The overall tone suggests challenges but also a proactive approach to addressing them.

Positives

• Revenues were essentially flat year-over-year.
• Tight expense management led to improved operating income both sequentially and year-over-year.
• The warranty businesses are showing signs of improvement, with expectations for more favorable comparisons in the coming quarters.
• Ravix, SPI, and DDI within KSX are performing well.
• The company is committed to growing its portfolio through acquisitions, targeting two to three new acquisitions per year with an annualized EBITDA of $1 million to $3 million each.
• Net debt decreased slightly from $35.3 million at the end of 2023 to $34.9 million as of March 31, 2024.

Negatives

• Consolidated revenue decreased slightly by 0.9%.
• The company experienced a net loss of $2.3 million, a significant drop from the previous year's net income.
• Adjusted consolidated EBITDA decreased to $2.1 million from $2.4 million.
• The extended warranty segment's adjusted EBITDA decreased due to higher claims expenses.
• KSX adjusted EBITDA declined due to ongoing softness in the nurse staffing business.

Risks

• Macroeconomic trends are impacting the company's businesses.
• The nurse staffing business within KSX is experiencing ongoing softness.
• Higher claims expenses are negatively affecting the extended warranty segment's profitability.
• The company's financial results are subject to risks and uncertainties that could cause actual results to differ materially from expectations.

Future Outlook

The company expects positive momentum within its existing portfolio of businesses in 2024 and aims to grow through two to three new acquisitions per year, each generating $1 million to $3 million in annualized EBITDA.

Management Comments

• Our first quarter financial results are largely in-line with our expectations given the macro-economic trends that have impacted our businesses for the past several quarters.
• Revenues were essentially flat, and EBITDA at our operating companies declined modestly.
• We are pleased that tight expense management allowed us to deliver improved Operating Income both sequentially and year over year.
• Our warranty businesses are improving and we expect more favorable comparisons in the quarters ahead.
• Within KSX, Ravix, SPI and DDI are all performing well, while the teams at CSuite and SNS are executing strategies aimed at igniting revenue growth and implementing improvements to business operations.
• Looking ahead, we continue to expect positive momentum within our existing portfolio of businesses in 2024.
• Importantly, we remain committed to growing our portfolio of businesses and delivering sustainable long-term growth in cash from operations by targeting two to three new acquisitions per year that will generate annualized EBITDA in the range of $1 million to $3 million each.

Industry Context

The results reflect the challenges faced by companies in the extended warranty and business services industries due to macroeconomic pressures and specific operational issues, such as the softness in nurse staffing.

Comparison to Industry Standards

• It is difficult to make a direct comparison without knowing the specific peer group of Kingsway. However, companies like Asurion (private) in the warranty space and staffing companies like AMN Healthcare (AMN) or Cross Country Healthcare (CCRN) in the healthcare staffing space could be considered as comparables.
• Kingsway's revenue decline of 0.9% is relatively small compared to some companies that have seen larger declines in the current economic climate. However, the shift from a $27.9 million profit to a $2.3 million loss is a significant change.
• The adjusted EBITDA of $2.1 million is lower than the previous year, indicating a potential challenge in maintaining profitability. Companies with similar business models are likely facing similar pressures on margins due to increased costs and economic uncertainty.
• The company's focus on acquisitions is a common strategy for growth in the industry, but the success of these acquisitions will be crucial for future performance.

Stakeholder Impact

• Shareholders may be concerned about the net loss and decreased profitability.
• Employees may be affected by the ongoing strategies to improve business operations.
• Customers may experience changes in service as the company implements operational improvements.
• Suppliers and creditors may be impacted by the company's financial performance.

Next Steps

• Management will host a conference call on May 8, 2024, to discuss the results.
• The company will host an Investor Day on May 20, 2024, in New York City.
• The company will continue to execute strategies aimed at igniting revenue growth and implementing improvements to business operations.
• Kingsway will continue to pursue acquisitions to grow its portfolio.

Key Dates

Keywords

financial results, EBITDA, revenue, net loss, extended warranty, KSX, share repurchase, acquisitions, operating income, debt